In the United States, data analytics are used to determine the price of drugs. But many patients don’t fit into neatly organized statistics, especially ones who have multiple diseases and, as a result, are denied therapies. In this week’s episode, we explore the method used in the U.S. to set drug prices, called the Cost per QALY or cost-effectiveness.

 

"Data in health care has never been meant to be static. We need to provide even greater scrutiny concerning these models and how they’re applied and make coverage decisions for life-saving biopharmaceuticals,” says Dr. Robert Popovian, Chief Science Policy Officer at the Global Healthy Living Foundation.

Among the highlights in this episode:

1:42: Listener review

2:15: Organizations that have global influence over patient care and access

3:30: How do these organizations define value in the marketplace?

4:07: A chronic patient doesn’t always benefit from this analytic approach to pricing drugs

4:35: “If the patient doesn’t fit the profile, they’re denied the therapy,” says Robert

5:00: Are these analytical tools misleading?

5:25: What happens if it ends up on a list in the U.S.? 

6:18: From year to year, medications on these lists change

7:25: Robert shares his final thoughts

Contact our hosts: 

Dr. Robert Popovian, Chief Science Policy Officer at GHLF, rpopovian@ghlf.org

Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF, cmertens@ghlf.org

We want to hear what you think. Send your comments, or a video or audio clip of yourself to Healthcarematters@GHLF.org.

Listen to all episodes of Healthcare Matters on our website or on your favorite podcast channel.

In the United States, data analytics are used to determine the price of drugs. But many patients don&rsquo;t fit into neatly organized statistics, especially ones who have multiple diseases and, as a result, are denied therapies. In this week&rsquo;s episode, we explore the method used in the U.S. to set drug prices, called&nbsp;the Cost per QALY or cost-effectiveness.
&nbsp;
"Data in health&nbsp;care has never been meant to be static. We need to provide even greater scrutiny concerning these models and how they&rsquo;re applied and make coverage decisions for life-saving biopharmaceuticals,&rdquo; says Dr. Robert Popovian, Chief Science Policy Officer at the Global Healthy Living Foundation.
Among the highlights in this episode:
1:42: Listener review
2:15: Organizations that have global influence over patient care and access
3:30: How do these organizations define value in the marketplace?
4:07: A chronic patient doesn&rsquo;t always benefit from this analytic approach to pricing drugs
4:35: &ldquo;If the patient doesn&rsquo;t fit the profile, they&rsquo;re denied the therapy,&rdquo; says Robert
5:00: Are these analytical tools misleading?
5:25: What happens if it ends up on a list in the U.S.?&nbsp;
6:18: From year to year, medications on these lists change
7:25: Robert shares his final thoughts
Contact our hosts: 
Dr. Robert Popovian, Chief Science Policy Officer at GHLF, <a href="mailto:rpopovian@ghlf.org">rpopovian@ghlf.org</a>
Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF, <a href="mailto:cmertens@ghlf.org">cmertens@ghlf.org</a>
We want to hear what you think. Send your comments, or a video or audio clip of yourself to <a href="mailto:Healthcarematters@GHLF.org">Healthcarematters@GHLF.org</a>.
Listen to all episodes of Healthcare Matters on <a href="https://ghlf.org/healthcarematters/">our website</a> or on your favorite podcast channel.

Welcome to Healthcare Matters! In this podcast, we talk about 'matters' in healthcare and why it matters to you! 

Our host Ben Blanc will speak with our talented Chief Science Officer Robert Popovian. And together, we will take on some pretty complex topics and distil them, so everyone can understand what is happening in the world of healthcare. 

The show is brought to you by the Global Healthy Living Foundation. 

www.ghlf.org

Welcome to Healthcare Matters! In this podcast, we talk about 'matters' in healthcare and why it matters to you! 
Our host Ben Blanc will speak with our talented Chief Science Officer Robert Popovian. And together, we will take on some pretty complex topics and distil them, so everyone can understand what is happening in the world of healthcare. 
The show is brought to you by the Global Healthy Living Foundation. 
www.ghlf.org

Healthcare Matters

A podcast that pulls back the curtain to help you make sense of complex healthcare economics and policy issues. Our goal is to help simplify the complexities in healthcare economics and policy issues for you.

The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Dr. Robert Popovian, Chief Science Policy Officer at GHLF and Ben Blanc, Associate Director, Digital Production and Engagement at GHLF.

A podcast that pulls back the curtain to help you make sense of complex healthcare economics and policy issues. Our goal is to help simplify the complexities in healthcare economics and policy issues for you.
The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Dr. Robert Popovian, Chief Science Policy Officer at GHLF and Ben Blanc, Associate Director, Digital Production and Engagement at GHLF.

Advertisement